Edward V Wancewicz

Edward V Wancewicz

UNVERIFIED PROFILE

Are you Edward V Wancewicz?   Register this Author

Register author
Edward V Wancewicz

Edward V Wancewicz

Publications by authors named "Edward V Wancewicz"

Are you Edward V Wancewicz?   Register this Author

14Publications

378Reads

12Profile Views

Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.

Neuron 2012 Jun;74(6):1031-44

Ludwig Institute for Cancer Research and Department of Cellular and Molecular Medicine, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuron.2012.05.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383626PMC
June 2012

Comparing in vitro and in vivo activity of 2'-O-[2-(methylamino)-2-oxoethyl]- and 2'-O-methoxyethyl-modified antisense oligonucleotides.

J Med Chem 2008 May 10;51(9):2766-76. Epub 2008 Apr 10.

Department of Medicinal Chemistry and Antisense Core Research, Isis Pharmaceuticals Inc., 1896 Rutherford Road, Carlsbad, California 92008, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm701537zDOI Listing
May 2008

Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity.

Oligonucleotides 2004 ;14(4):263-73

Department of Pharmacology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-9041, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/oli.2004.14.263DOI Listing
May 2005

Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis.

Cancer Res 2002 Oct;62(19):5393-8

Department of Surgery, McGill University Health Center, Royal Victoria Hospital, Montreal, Quebec, H3A 1A4 Canada.

View Article

Download full-text PDF

Source
October 2002